Scynexis SCYX
NASDAQ SCYX
$5.24 +0.09 (+1.65%)
At close: Aug 20, 2026 · 12:42 PM UTC

Scynexis (SCYX) Gains from Investment Securities (2013 - 2026)

Scynexis' (SCYX) quarterly Gains from Investment Securities came in at $5.2 million in Q1 2026, up 279.27% YoY from $1.4 million in Q1 2025, and up 512.33% on a QoQ basis from -$1.3 million in Q4 2025.

Scynexis (SCYX) Gains from Investment Securities (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has 13 years of Gains from Investment Securities data on file, last reported at $5.2 million in Q1 2026.

  • Quarterly Gains from Investment Securities rose 279.27% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 134.12% YoY) and the FY2025 annual result came in at -$5.8 million, up 58.2% from the prior year.
  • Gains from Investment Securities improved to $5.2 million in Q1 2026, from -$1.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $21.7 million in Q3 2022 to a low of -$10.0 million in Q1 2022.
  • A 5-year average of -$1.1 million and a median of -$2.9 million in 2025 frame the typical range for Gains from Investment Securities.
  • Annual changes were most pronounced in 2022 — Gains from Investment Securities sank 673.92% — and 2023, when it jumped 316.08%.
  • Tracing SCYX's Gains from Investment Securities over 5 years: stood at -$9.1 million in 2022, then jumped by 69.18% to -$2.8 million in 2023, then slipped by 14.79% to -$3.2 million in 2024, then surged by 60.39% to -$1.3 million in 2025, then surged by 512.33% to $5.2 million in 2026.
  • The last three Gains from Investment Securities figures came in at $5.2 million (Q1 2026), -$1.3 million (Q4 2025), and $640000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Scynexis 61.90 Mn -52.80 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.15 Mn
Jun 30, 2026 -14.15 Mn
Mar 31, 2026 5.25 Mn
Mar 31, 2026 5.25 Mn
Dec 31, 2025 -1.27 Mn
Dec 31, 2025 -1.27 Mn
Sep 30, 2025 640,000.00
Sep 30, 2025 640,000.00
Jun 30, 2025 -2.17 Mn
Jun 30, 2025 -2.17 Mn
Mar 31, 2025 -2.93 Mn
Mar 31, 2025 -2.93 Mn
Dec 31, 2024 -3.21 Mn
Dec 31, 2024 -3.21 Mn
Sep 30, 2024 -6.80 Mn
Sep 30, 2024 -6.80 Mn
Jun 30, 2024 5.76 Mn
Jun 30, 2024 5.76 Mn
Mar 31, 2024 -9.60 Mn
Mar 31, 2024 -9.60 Mn